Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Daoussis

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Arthritis Research & Therapy|December 6, 2018
Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort studyStylianos Panopoulos, Maria Tektonidou, Alexandros A Drosos, et al.
Rheumatology International|April 21, 2022
ACTH vs steroids for the treatment of acute gout in hospitalized patients: a randomized, open label, comparative studyDimitrios Daoussis, Panagiotis Kordas, George Varelas, et al.
Clinical and Experimental Rheumatology|July 8, 2016
Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life studyDimitrios Vassilopoulos, Evie M Delicha, Loukas Settas, et al.
The Israel Medical Association Journal : IMAJ|April 30, 2019
The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through SynergyLazaros I Sakkas, Dimitrios P Bogdanos, Dimitrios Boumpas, et al.
Seminars in Arthritis and Rheumatism|November 13, 2022
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working groupNilasha Ghosh, Nina Couette, Wouter H van Binsbergen, et al.
Cancer Immunology, Immunotherapy : CII|June 24, 2021
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, Sofia Lampaki, Georgia-Angeliki Koliou, et al.
Frontiers in Medicine|January 26, 2023
Clinical features and outcomes of patients with myositis associated-interstitial lung diseaseTheodoros Karampitsakos, Vasilios Tzilas, Ourania Papaioannou, et al.
Mediterranean Journal of Rheumatology|January 29, 2024
Disease Profile and Achievement of Therapeutic Goals in a Modern, Nationwide Cohort of 923 Patients with Psoriatic ArthritisGeorge E Fragoulis, Charalampos Papagoras, Sousana Gazi, et al.
Seminars in Arthritis and Rheumatism|February 2, 2025
Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registryCharalampos Papagoras, George E Fragoulis, Nikolaos Fytanidis, et al.
Rheumatology International|July 8, 2026
Disease-related and psychosocial factors associated with difficult-to-manage and treatment-refractory axial spondyloarthritis: insights from the Greek AxSpA RegistryN Kougkas, Konstantinos Tsafis, Dimitrios Deligeorgakis, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Arthritis Research & Therapy|December 6, 2018
Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort studyStylianos Panopoulos, Maria Tektonidou, Alexandros A Drosos, et al.
Rheumatology International|April 21, 2022
ACTH vs steroids for the treatment of acute gout in hospitalized patients: a randomized, open label, comparative studyDimitrios Daoussis, Panagiotis Kordas, George Varelas, et al.
Clinical and Experimental Rheumatology|July 8, 2016
Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life studyDimitrios Vassilopoulos, Evie M Delicha, Loukas Settas, et al.
The Israel Medical Association Journal : IMAJ|April 30, 2019
The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through SynergyLazaros I Sakkas, Dimitrios P Bogdanos, Dimitrios Boumpas, et al.
Seminars in Arthritis and Rheumatism|November 13, 2022
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working groupNilasha Ghosh, Nina Couette, Wouter H van Binsbergen, et al.
Cancer Immunology, Immunotherapy : CII|June 24, 2021
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, Sofia Lampaki, Georgia-Angeliki Koliou, et al.
Frontiers in Medicine|January 26, 2023
Clinical features and outcomes of patients with myositis associated-interstitial lung diseaseTheodoros Karampitsakos, Vasilios Tzilas, Ourania Papaioannou, et al.
Mediterranean Journal of Rheumatology|January 29, 2024
Disease Profile and Achievement of Therapeutic Goals in a Modern, Nationwide Cohort of 923 Patients with Psoriatic ArthritisGeorge E Fragoulis, Charalampos Papagoras, Sousana Gazi, et al.
Seminars in Arthritis and Rheumatism|February 2, 2025
Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registryCharalampos Papagoras, George E Fragoulis, Nikolaos Fytanidis, et al.
Rheumatology International|July 8, 2026
Disease-related and psychosocial factors associated with difficult-to-manage and treatment-refractory axial spondyloarthritis: insights from the Greek AxSpA RegistryN Kougkas, Konstantinos Tsafis, Dimitrios Deligeorgakis, et al.
Pageof 11